Reference (A7-May-21)
[1] Anna Lipońska, Farès Ousalem, Daniel P. Aalberts, John F. Hunt, and Grégory Boël. (Year). The new strategies to overcome challenges in protein production in bacteria, microbial biotechnology. 2019 Jan; 12(1): 44–47. (https://dx.doi.org/10.1111%2F1751-7915.13338)
[2] Bo Ma, Xiaoyang Guan, Yaohao Li, Shiying Shang, Jing Li and Zhongping Tan. (2020). Protein Glycoengineering: An Approach for Improving Protein Properties, frontiers in Chemistry 8: 622. https://dx.doi.org/10.3389%2Ffchem.2020.00622.
Books: Author or editors, book title, publication information (city, state, publishing company), year of publication.
[3] Marie-Eve Lalonde, Yves Durocher. (2017) Therapeutic glycoprotein production in mammalian cells, J. Biotechnol: 251: 128-140. https://doi.org/10.1016/j.jbiotec.2017.04.028
[4] Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem. 1982;51:531-54. doi: 10.1146/annurev.bi.51.070182.002531. PMID: 6287920.
[5] Fischer U, Huber J, Boelens WC, Mattaj IW, Lührmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 1995 Aug 11;82(3):475-83. doi: 10.1016/0092-8674(95)90436-0. PMID: 7543368.
[6] Lifely M. R., Hale C., Boyce S., Keen M. J., Phillips J. (1995). Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology 5, 813–822. 10.1093/glycob/5.8.813
